Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-27T09:56:00.934Z Has data issue: false hasContentIssue false
  • English
  • Français

Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success

Published online by Cambridge University Press:  03 January 2018

Albert Seoane ,
Genís Carrasco ,
Lluís Cabré ,
Ana Puiggrós ,
Eustaqui Hernández ,
Miguel Álvarez ,
Josep Costa ,
Ricard Molina  and
Gaudi Sobrepere
Albert Seoane
Affiliation:
PARIS (Professionals Associats per la Rehabilitació i la Salut) Association, Barcelona, Spain
Genís Carrasco*
Affiliation:
Quality of Sedation Research Group, Intensive Care Service, SCIAS-Hospital de Barcelona, Barcelona, Spain
Lluís Cabré
Affiliation:
Quality of Sedation Research Group, Intensive Care Service, SCIAS-Hospital de Barcelona, Barcelona, Spain
Ana Puiggrós
Affiliation:
PARIS (Professionals Associats per la Rehabilitació i la Salut) Association, Barcelona, Spain
Eustaqui Hernández
Affiliation:
PARIS (Professionals Associats per la Rehabilitació i la Salut) Association, Barcelona, Spain
Miguel Álvarez
Affiliation:
PARIS (Professionals Associats per la Rehabilitació i la Salut) Association, Barcelona, Spain
Josep Costa
Affiliation:
Quality of Sedation Research Group, Intensive Care Service, SCIAS-Hospital de Barcelona, Barcelona, Spain
Ricard Molina
Affiliation:
Quality of Sedation Research Group, Intensive Care Service, SCIAS-Hospital de Barcelona, Barcelona, Spain
Gaudi Sobrepere
Affiliation:
Quality of Sedation Research Group, Intensive Care Service, SCIAS-Hospital de Barcelona, Barcelona, Spain
*
Dr G. Carrasco, Intensive Care Service, SCIAS-Hospital de Barcelona, Avda Diagonal 660, 08034 Barcelona, Spain
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

New methods of rapid opiate detoxification, under intravenous sedation, can detoxify heroin-addicted patients in 24 hours. Their clinical application has been limited by the lack of studies establishing both efficacy and safety.

Method

In a randomised, controlled study, 300 treatment-refractory, heroin-addicted patients received rapid intravenous detoxification treatment (naloxone infusion, 0.06–0.08 mg/kg, then oral naltrexone 50 mg/day) under either monitored light intravenous sedation or unmonitored deep intravenous sedation.

Results

All patients were successfully detoxified and 93% remained abstinent one month later. Severity of withdrawal, according to the Wang Scale modified by Loimer, was 4.9 (s.d. 3.0) points in the light sedation group and 4.8 (s.d. 2.9) in the deep sedation group (P=0.26). Two patients (1.3%) in the light sedation group and four (2.6%) in the deep sedation group required tracheal intubation (P=0.31). There was only one severe complication, a case of nosocomial aspirative pneumonia which improved with antibiotic treatment.

Conclusions

Successful rapid intravenous detoxification can be achieved using relatively light levels of sedation.

Type
Papers
Information
The British Journal of Psychiatry , Volume 171 , Issue 4 , October 1997 , pp. 340 - 345
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

∗

Presented, in part, at the XV Annual Meeting of the Catalan Intensive Care Society, Barcelona, November 24–25, 1994.

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn. revised). Washington, DC: APA.Google Scholar
Altman, D. G. (ed.) (1991) Sample size, hypothesis and power. In Practical Approaches to Medical Research, pp. 396–400. London: Chapman Hall.Google Scholar
Brewer, C. (1995) Attitudes to abortion, methadone maintenance and humane opiate withdrawal among health professionals: A depressing analogy. Addiction Research. 3, 1–5.Google Scholar
Brewer, C. (1996) On the specific effectiveness and under-valuing of pharmacological treatments for addiction: a comparison of methadone, naltrexone and disulfiram with psychosocial interventions. Addiction Research, 3, 297–313.Google Scholar
Carrasco, C., Molina, R., Costa, J., et al (1993) Propofol versus midazolam in sedation of critically ill patients: cost-benefit analysis. Chest, 103, 557–567.Google Scholar
Charney, D. S., Heninger, G. R. & Kleber, H. D. (1986) The combined use of Clonidine and naltrexone as a safe, rapid and effective treatment of abrupt withdrawal from methadone. American Journal of Psychiatry, 143, 831–837.Google ScholarPubMed
Fishbain, D. A., Rosomoff, H. L., Cutler, R., et al (1993) Opiate detoxification protocols. A clinical manual. Annals of Clinical Psychiatry, 5, 53–65.CrossRefGoogle ScholarPubMed
Froehlich, F., Gonvers, J. J. & Fried, M. (1994) Conscious sedation, clinically relevant complications and monitoring of endoscopy: results of a nationwide survey in Switzerland. Endoscopy. 26, 231–234.Google Scholar
Gossop, M., Griffiths, P., Bradley, B., et al (1989) Opiate withdrawal symptoms in response to 10 day methadone withdrawal programmes. British Journal of Psychiatry, 154, 360–363.Google Scholar
Kosten, T. R. & Kleber, H. D. (1984) Strategies to improve compliance with narcotic agonist. American Journal of Drug and Alcohol Abuse, 10, 249–266.Google Scholar
Legarda, J. J. & Gossop, M. (1994) A 24-hour inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug and Alcohol Dependence, 35, 91–93.Google Scholar
Loimer, N., Schmid, R., Presslich, O., et al (1989) Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. Journal of Psychiatric Research, 23, 81–86.Google Scholar
Loimer, N., Schmid, R., Lenz, K., et al (1990) Acute blocking of naloxone precipitated opiate withdrawal symptoms by methohexitone. British Journal of Psychiatry, 157, 748–752.Google Scholar
Loimer, N., Lenz, K., Schmid, R., et al (1991) Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. American Journal of Psychiatry, 148, 933–935.Google Scholar
O'Connor, P. G., Waugh, M. E., Carroll, K. M., et al (1995) Primary-care based ambulatory opioid detoxification. Journal of General Internal Medicine, 10, 255–260.Google Scholar
Partridge, B. L. & Ward, C. F. (1986) Pulmonary edema following low-dose naloxone administration. Anesthesiology, 65, 709–710.Google Scholar
Plan Nacional sobre Droges (1994) Prevalencia de la drogadicción. In Memoria 1993 (eds Ministerio de Justicia e Interior), pp. 10–12. Madrid: Ministerio de Justicia e Interior.Google Scholar
Riordan, C. H. & Kleber, H. (1980) Rapid opiate detoxification with Clonidine and naltrexone. Lancet, i, 1079–1080.Google Scholar
San, L., Puig, M., Bulbena, A., et al (1995) High risk of ultrashort noninvasive opiate detoxification. American Journal of Psychiatry, 152, 6.Google Scholar
Senft, R. (1991) Experience with Clonidine naltrexone for rapid opiate detoxification. Journal of Substance Abuse Treatment, 8, 257–259.Google Scholar
Stine, S. M. & Kosten, T. R. (1992) Use of drug combinations in treatment of opioid withdrawal. Journal of Clinical Psychopharmacology, 12, 203–209.Google Scholar
Vining, E., Kosten, T. R. & Kleber, H. D. (1988) Clinical utility of rapid Clonidine–naltrexone detoxification for opioid abusers. British Journal of Addiction, 83, 567–575.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.